Seraphina Therapeutics Adds Nutrition Industry Executive Bruce Brown to Lead Growth Strategy for C15:0

SAN DIEGO, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Today, Seraphina Therapeutics, the pioneer in healthspan-extending nutrient research, announced an addition to its leadership team. Bruce Brown, formerly the End Use Market Executive for Kerry, joins the company to lead the growth strategy for C15:0, the first essential fatty acid to be discovered in over 90 years. Bruce Brown joins Seraphina Therapeutics from Kerry Group where he led strategy and commercial responsibilities for the dietary supplement End ...